American Pharmaceutical Partners announced it doesn't expect to get approval for its version of ceftriaxone for injection soon, citing information the drug company received this week from a raw material supplier that was inspected by the Food and Drug Administration. Ceftriaxone is the generic form of Roche's Rocephin, a cephalosporin antibiotic.
- read this report from TheStreet.com for more